Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
The University of New South Wales
With
Duke University
Emory University
Sheppard Pratt Health System
University of Medicine and Dentistry of New Jersey
University of Texas
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
18 years of age or above.
Meets criteria for a DSM-IV Major Depressive Episode with duration of at least 4 weeks.
Total score ≥ 20 on the Montgomery-Asberg Depression Rating Scale at study entry.
You may not be if
Current episode duration greater than 3 years.
Failed more than 3 adequate antidepressant trials in current episode.
DSM-IV psychotic disorder.
Drug or alcohol abuse or dependence (preceding 3 months).
Inadequate response to ECT in the current episode of depression.
Rapid clinical response required, e.g., high suicide risk.
Significant acute suicide risk, defined as follows: suicide attempt within the previous 6 months that required medical treatment; or ≥ 2 suicide attempts in the past 12 months; or has a clear-cut plan for suicide and states that they cannot guarantee that they will call their regular psychiatrist or the investigator if the impulse to implement the plan becomes substantial during the study; or in the investigator's opinion, is likely to attempt suicide within the next 6 months.
Clinically defined neurological disorder or insult.
Metal in the cranium, skull defects, or skin lesions on scalp (cuts, abrasions, rash) at proposed electrode sites.
Pregnancy.
Concurrent long acting benzodiazepines, ritalin or dexamphetamine medication.
Clareo Health | Investigating tDCS as a Treatment for Unipolar and Bipolar Depression
